Literature DB >> 25054873

Applicability of crystalline cellulose membrane in the treatment of skin wounds induced in Wistar rats.

Milena Colonhese Camargo1, Rosa Maria Barilli Nogueira2, Osimar de Carvalho Sanches3, Maria da Graça Saab4, Aline Batista4, Diane Vasconcelos5, Letícia Yuri Luvisotto5, Marco Aurélio Aparecido Lúcio5.   

Abstract

PURPOSE: To evaluate the healing of skin wounds induced experimentally in rats using a crystalline cellulose membrane (Veloderm®).
METHODS: Thirty-two rats were divided into two groups: control group (CG) wounds treated with a solution of 0.9% sodium chloride and Veloderm® group (VG) wounds treated with a crystalline cellulose membrane. The rats were evaluated at different times over twenty-six days.
RESULTS: Weight loss was observed in the animals from both groups in the early stages, with greater weight in the VG animals at the end. Times of predominant hypothermia, pink color of the wound in both groups over all time points, increased granulation tissue in the CG animals, the presence of slight oozing from the wound and feature in the VG animals, more serous exudation of the bloody feature, greater wound contraction and pain in the CG animals and an absence of pain and earlier complete wound healing in the VG rats were also observed.
CONCLUSION: The crystalline cellulose membrane is effective in the treatment of wounds in rats, easy to use, protects and maintains the humidity of the wound, decreases pain, eases the visualization and control of the evolution of the lesion.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25054873     DOI: 10.1590/s0102-86502014000700004

Source DB:  PubMed          Journal:  Acta Cir Bras        ISSN: 0102-8650            Impact factor:   1.388


  1 in total

1.  Effects of different cellulose membranes regenerated from Styela clava tunics on wound healing.

Authors:  Sung Hwa Song; Keum Yong Seong; Ji Eun Kim; Jun Go; Eun Kyoung Koh; Ji Eun Sung; Hong Joo Son; Young Jin Jung; Hye Sung Kim; Jin Tae Hong; Dae Youn Hwang
Journal:  Int J Mol Med       Date:  2017-03-20       Impact factor: 4.101

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.